Cargando…

Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis

Cardiac amyloidosis (CA) describes the pathological process of amyloid protein deposition in the extracellular space of the myocardium. Unfortunately, the diagnosis of CA is often made late and when the disease process is advanced. However, advances in cardiovascular imaging have allowed for better...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agha, Ali M, Parwani, Purvi, Guha, Avirup, Durand, Jean B, Iliescu, Cezar A, Hassan, Saamir, Palaskas, Nicolas L, Gladish, Greg, Kim, Peter Y, Lopez-Mattei, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Heart Failure and Cardiomyopathies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173267/ https://www.ncbi.nlm.nih.gov/pubmed/30305910 http://dx.doi.org/10.1136/openhrt-2018-000881

Ejemplares similares

Prognosis of light chain amyloidosis: a multivariable analysis for survival prediction in patients with cardiac involvement proven by endomyocardial biopsy
por: Aurich, Matthias, et al.
Publicado: (2023)

Machine learning-derived electrocardiographic algorithm for the detection of cardiac amyloidosis
por: Schrutka, Lore, et al.
Publicado: (2022)

Can myocardial work indices contribute to the exploration of patients with cardiac amyloidosis?
por: Roger-Rollé, Aénora, et al.
Publicado: (2020)

Cardiac Magnetic Resonance Predicting Outcomes Among Patients at Risk for Cardiac AL Amyloidosis
por: Agha, Ali M., et al.
Publicado: (2021)

Value of natriuretic peptides and tissue Doppler imaging in the estimation of left ventricular filling pressure in patients with cardiac amyloidosis
por: Brun, Stéphanie, et al.
Publicado: (2019)

Multimodality imaging in carcinoid heart disease
por: Agha, Ali M, et al.
Publicado: (2019)

The role of cardiac biomarkers for predicting left ventricular dysfunction and cardiovascular mortality in acute exacerbations of COPD
por: Buchan, Alice, et al.
Publicado: (2015)

Cardiovascular magnetic resonance T2* mapping for the assessment of cardiovascular events in hypertrophic cardiomyopathy
por: Gastl, Mareike, et al.
Publicado: (2020)

Complications and prognosis of patients undergoing apical or septal right ventricular pacing
por: Spath, Nick B, et al.
Publicado: (2019)

Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy
por: Ho, Jennifer E, et al.
Publicado: (2017)

Prognosis and risk stratification in patients with decompensated heart failure receiving inotropic therapy
por: Gomes, Clara, et al.
Publicado: (2018)

Vascular comorbidities worsen prognosis of patients with heart failure hospitalised with COVID-19
por: Mok, Jacob, et al.
Publicado: (2021)

Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction
por: Salah, Khibar, et al.
Publicado: (2019)

Effects of exercise during chemotherapy for breast cancer on long-term cardiovascular toxicity
por: Naaktgeboren, Willeke R, et al.
Publicado: (2023)

Diastolic dysfunction in people with HIV without known cardiovascular risk factors in Western Kenya
por: Woldu, Bethel, et al.
Publicado: (2022)

Cardiovascular medication in patients with raised NT-proBNP, but no heart failure in the SHEAF registry
por: Wolodimeroff, Elena, et al.
Publicado: (2022)

Characteristics and outcomes of patients with suspected heart failure referred in line with National Institute for Health and Care Excellence guidance
por: Zheng, Alice, et al.
Publicado: (2020)

CONTRIBUTION OF CARDIOVASCULAR DISEASE TO ADVERSE HOSPITAL OUTCOMES IN COVID-19 HOSPITALIZATIONS: RESULTS FROM NATIONAL INPATIENT SAMPLE
por: Rubens, Muni, et al.
Publicado: (2023)

Risk stratification for major adverse cardiac events and ventricular tachyarrhythmias by cardiac MRI in patients with cardiac sarcoidosis
por: Yasuda, Masakazu, et al.
Publicado: (2016)

Comparative cardiovascular outcomes of novel drugs as an addition to conventional triple therapy for heart failure with reduced ejection fraction (HFrEF): a network meta-analysis of randomised controlled trials
por: Suebsaicharoen, Thanakit, et al.
Publicado: (2023)

Ferumoxytol-enhanced MRI in patients with prior cardiac transplantation
por: Stirrat, Colin G, et al.
Publicado: (2019)

Extracellular cardiac matrix biomarkers in patients with reduced ejection fraction heart failure as predictors of response to cardiac resynchronisation therapy: a systematic review
por: McAloon, Christopher J, et al.
Publicado: (2017)

Measures of endothelial dysfunction predict response to cardiac resynchronisation therapy
por: Warriner, David R, et al.
Publicado: (2016)

Exploring the acceptability of implantable defibrillators in patients with cardiac dystrophinopathy and carers
por: Hiermeier, Ursula M, et al.
Publicado: (2020)

Update in imaging of cancer therapy-related cardiac toxicity in adults
por: de Baat, Esmée C, et al.
Publicado: (2021)

Influence of sex and phenotype on cardiac outcomes in patients with Fabry disease
por: El Sayed, Mohamed, et al.
Publicado: (2021)

Demographic features and prevalence of myocarditis in patients undergoing transarterial endomyocardial biopsy for unexplained cardiomyopathy
por: Hassan, Ayman K.M., et al.
Publicado: (2017)

Calibrated integrated backscatter and myocardial fibrosis in patients undergoing cardiac surgery
por: Prior, David L, et al.
Publicado: (2015)

Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure
por: Mealing, Stuart, et al.
Publicado: (2016)

Cardiac mechanics and dysfunction with anthracyclines in the community: results from the PREDICT study
por: Narayan, Hari K, et al.
Publicado: (2017)

Scar burden is an independent and incremental predictor of cardiac resynchronisation therapy response
por: Harb, Serge C, et al.
Publicado: (2019)

Moderate excess alcohol consumption and adverse cardiac remodelling in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2022)

Inflammation and echocardiographic parameters of ventricular hypertrophy in a cohort with preserved cardiac function
por: Medenwald, D, et al.
Publicado: (2014)

Early-onset cardiac dysfunction following allogeneic haematopoietic stem cell transplantation
por: Moriyama, Shohei, et al.
Publicado: (2022)

Does recovery from submaximal exercise predict response to cardiac resynchronisation therapy?
por: Wouters, Philippe, et al.
Publicado: (2022)

Superiority of left heart deformation in early anthracycline-related cardiac dysfunction detection
por: Giang M, Nhat, et al.
Publicado: (2023)

ECG characteristics according to the presence of late gadolinium enhancement on cardiac MRI in hypertrophic cardiomyopathy
por: Grall, Sylvain, et al.
Publicado: (2014)

Individual patient data network meta-analysis of mortality effects of implantable cardiac devices
por: Woods, B, et al.
Publicado: (2015)

Lamin mutation location predicts cardiac phenotype severity: combined analysis of the published literature
por: Captur, Gabriella, et al.
Publicado: (2018)

Smoking intensity and duration is associated with cardiac structure and function: the ECHOcardiographic Study of Hispanics/Latinos
por: Leigh, J Adam, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ks1n1ooafrlf5703spbloimrrl